Homburger on Hevolution’s USD 30.7m investment

Homburger has advised Hevolution Foundation on its participation in a Series A investment round in Vandria, which raised a total of USD 30.7 million. Hevolution Foundation, a global non-profit organisation dedicated to advancing health span science through grants and early-stage investments, joined other investors in providing additional funding to support Vandria’s research and development efforts.

Vandria specialises in discovering and developing novel small molecules that induce mitophagy, with a focus on treating age-related and chronic diseases. The Series A funding will enable the company to continue advancing its therapeutic solutions aimed at these critical areas of healthcare.

The Homburger legal team advising Hevolution Foundation was led by Andreas Müller (pictured left) and Marc Abplanalp (pictured right) (both corporate/M&A), along with Luca Dal Molin and Joel Fink (both IP/IT) and Jeremy Reichlin (Employment and Executive Compensation).